Brachytherapy Market By Product Type (Seeds, Applicators and Afterloaders, Electronic Brachytherapy), By Technique (High Dose Rate (HDR), Low Dose Rate (LDR)), By Application (Gynecological Cancer, Prostate Cancer, Breast Cancer, Others), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The brachytherapy market was valued at $826.04 million in 2021, and is projected to reach $1,631.74 million by 2031, registering a CAGR of 7.1% from 2022 to 2031.
Brachytherapy is a method in which radioactive material is placed near the tumor within the body of the patient. The radioactive material destroys cancer cells by targeting them with radiation and stopping them dividing and growing. This method is also called internal radiation therapy. Brachytherapy procedure is used to treat various type of cancers such as breast cancer, cervical cancer, prostate cancer, and eye cancer. Brachytherapy can be safely delivered high dose of radiation at one time. Therefore, overall time of treatment can be shorter and lower the risk of recurrence of cancer with brachytherapy. The shorter treatment time with brachytherapy procedure makes it more special and important for the treatment of cancer.
Major factors driving growth of the brachytherapy market include rise in technological advancement in brachytherapy, and surge in prevalence of prostate cancer, breast cancer, cervical cancer and other cancers among global population. For instance, according to American Cancer Society, in 2021, it was that estimated 1.9 million new cancer cases was diagnosed and 608,570 people died due to cancer in U.S. According to this report, in 2021, in U.S., estimated new cases of female breast cancer were 281,550, uterine cervix cancer were 14,480, colon & rectum cancer were 149,500, and uterine corpus cancer were 66,570. According to World Health Organization (WHO) report 2021, each year, approximately 400,000 children develop cancer. Overall cancer incidence rates, or rates of new cancers, continue to rise slightly in women and children that further drives the growth of the brachytherapy market.
In addition, rise in demand of minimal invasive procedures, increase in awareness regarding treatment of cancer at early stages, precisely and accurately delivery of radiation to the tumor in this procedure, thus propel the adoption of brachytherapy and drives the growth of the brachytherapy market.
However, high costs of brachytherapy, health risks and complications associated with exposure to radiation are expected to hamper the brachytherapy market growth. On the contrary, unmet medical demands in developing countries and lucrative opportunities in emerging economies are expected to create immense opportunities for brachytherapy device manufacturers in the future.
Furthermore, the healthcare business is projected to witness growth, owing to a rise in the number of inherited cancers, rise in research of advanced brachytherapy for reducing its side effects boosting the growth of brachytherapy market. In addition, the increase in number of hospitals, and specialty clinics that offer brachytherapy procedure for the treatment of cancer and rise in awareness regarding use of brachytherapy drive the growth of brachytherapy market in developing countries like India, China. This is anticipated to offer remunerative opportunities for key players to invest in the market during the forecast period.
Moreover, rise in R&D investments in discovery & development of effective brachytherapy product, significant increase in capital income in developed countries, and surge in key strategies including product launch, collaboration, merger, acquisition adopted by key players, drive the growth of the brachytherapy market.
For instance, in April 2021, Siemens Healthineers AG announced that it has successfully completed the acquisition of Varian Medical Systems, Inc.. Varian and Siemens Healthineers, company will address the growing need for personalized, data-driven diagnosis and precision cancer care that enables to people to fight back against globally increasing cancer rates. The combined company is creating a unique, highly integrated portfolio of imaging, laboratory diagnostics, artificial intelligence and treatment for the global fight against cancer with significant potential for increased value creation. The acquisition aligns perfectly with the upgrading phase of Siemens Healthineers strategy.
The brachytherapy market is segmented on the basis of product type, technique, application, end user, and region. On the basis of product type, the market is classified into seeds, applicators & afterloaders, and electronic brachytherapy. On the basis of technique, the market is classified into high dose rate (HDR), and low dose rate (LDR). On the basis of application, the market is classified into gynecological cancer, prostate cancer, breast cancer, and others. On the basis of end user, it is fragmented into hospitals, specialty clinics, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major players profiled in the report are Argon Medical, Carl Zeiss AG, Eckert & Ziegler BEBIG, Elekta AB, Icad, Inc., Isoaid, Isoray Medical, Inc, Merit Medical Systems, Inc, Siemens AG, and Theragenics Corporation.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the brachytherapy market analysis from 2021 to 2031 to identify the prevailing brachytherapy market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the brachytherapy market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global brachytherapy market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
By Technique
High Dose Rate (HDR)
Low Dose Rate (LDR)
By End User
Hospitals
Specialty Clinics
Others
By Application
Gynecological Cancer
Prostate Cancer
Breast Cancer
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Argon Medical Devices, Inc.
Eckert & Ziegler BEBIG
Elekta AB
iCAD, Inc.
Siemens AG
isoray medical, inc.
Merit Medical Systems, Inc.
Theragenics Corporation
IsoAid
Carl Zeiss AG
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate bargaining power of buyers
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate threat of new entrants
- 3.3.5. Moderate intensity of rivalry
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Rise in prevalence of cancer
- 3.4.1.2. Increase in geriatric population
- 3.4.2. Restraints
- 3.4.2.1. Health risks and complications associated with brachytherapy
- 3.4.3. Opportunities
- 3.4.3.1. High growth potential in developing economies
- 3.5. COVID-19 Impact Analysis on the market
- CHAPTER 4: BRACHYTHERAPY MARKET, BY PRODUCT TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Seeds
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Applicators and Afterloaders
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.4. Electronic Brachytherapy
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- CHAPTER 5: BRACHYTHERAPY MARKET, BY TECHNIQUE
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. High Dose Rate (HDR)
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Low Dose Rate (LDR)
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- CHAPTER 6: BRACHYTHERAPY MARKET, BY APPLICATION
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Gynecological Cancer
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Prostate Cancer
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Breast Cancer
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- 6.5. Others
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by region
- 6.5.3. Market share analysis by country
- CHAPTER 7: BRACHYTHERAPY MARKET, BY END USER
- 7.1. Overview
- 7.1.1. Market size and forecast
- 7.2. Hospitals
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
- 7.3. Specialty Clinics
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
- 7.4. Others
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country
- CHAPTER 8: BRACHYTHERAPY MARKET, BY REGION
- 8.1. Overview
- 8.1.1. Market size and forecast By Region
- 8.2. North America
- 8.2.1. Key trends and opportunities
- 8.2.2. Market size and forecast, by Product Type
- 8.2.3. Market size and forecast, by Technique
- 8.2.4. Market size and forecast, by Application
- 8.2.5. Market size and forecast, by End User
- 8.2.6. Market size and forecast, by country
- 8.2.6.1. U.S.
- 8.2.6.1.1. Key market trends, growth factors and opportunities
- 8.2.6.1.2. Market size and forecast, by Product Type
- 8.2.6.1.3. Market size and forecast, by Technique
- 8.2.6.1.4. Market size and forecast, by Application
- 8.2.6.1.5. Market size and forecast, by End User
- 8.2.6.2. Canada
- 8.2.6.2.1. Key market trends, growth factors and opportunities
- 8.2.6.2.2. Market size and forecast, by Product Type
- 8.2.6.2.3. Market size and forecast, by Technique
- 8.2.6.2.4. Market size and forecast, by Application
- 8.2.6.2.5. Market size and forecast, by End User
- 8.2.6.3. Mexico
- 8.2.6.3.1. Key market trends, growth factors and opportunities
- 8.2.6.3.2. Market size and forecast, by Product Type
- 8.2.6.3.3. Market size and forecast, by Technique
- 8.2.6.3.4. Market size and forecast, by Application
- 8.2.6.3.5. Market size and forecast, by End User
- 8.3. Europe
- 8.3.1. Key trends and opportunities
- 8.3.2. Market size and forecast, by Product Type
- 8.3.3. Market size and forecast, by Technique
- 8.3.4. Market size and forecast, by Application
- 8.3.5. Market size and forecast, by End User
- 8.3.6. Market size and forecast, by country
- 8.3.6.1. Germany
- 8.3.6.1.1. Key market trends, growth factors and opportunities
- 8.3.6.1.2. Market size and forecast, by Product Type
- 8.3.6.1.3. Market size and forecast, by Technique
- 8.3.6.1.4. Market size and forecast, by Application
- 8.3.6.1.5. Market size and forecast, by End User
- 8.3.6.2. France
- 8.3.6.2.1. Key market trends, growth factors and opportunities
- 8.3.6.2.2. Market size and forecast, by Product Type
- 8.3.6.2.3. Market size and forecast, by Technique
- 8.3.6.2.4. Market size and forecast, by Application
- 8.3.6.2.5. Market size and forecast, by End User
- 8.3.6.3. UK
- 8.3.6.3.1. Key market trends, growth factors and opportunities
- 8.3.6.3.2. Market size and forecast, by Product Type
- 8.3.6.3.3. Market size and forecast, by Technique
- 8.3.6.3.4. Market size and forecast, by Application
- 8.3.6.3.5. Market size and forecast, by End User
- 8.3.6.4. Italy
- 8.3.6.4.1. Key market trends, growth factors and opportunities
- 8.3.6.4.2. Market size and forecast, by Product Type
- 8.3.6.4.3. Market size and forecast, by Technique
- 8.3.6.4.4. Market size and forecast, by Application
- 8.3.6.4.5. Market size and forecast, by End User
- 8.3.6.5. Spain
- 8.3.6.5.1. Key market trends, growth factors and opportunities
- 8.3.6.5.2. Market size and forecast, by Product Type
- 8.3.6.5.3. Market size and forecast, by Technique
- 8.3.6.5.4. Market size and forecast, by Application
- 8.3.6.5.5. Market size and forecast, by End User
- 8.3.6.6. Rest of Europe
- 8.3.6.6.1. Key market trends, growth factors and opportunities
- 8.3.6.6.2. Market size and forecast, by Product Type
- 8.3.6.6.3. Market size and forecast, by Technique
- 8.3.6.6.4. Market size and forecast, by Application
- 8.3.6.6.5. Market size and forecast, by End User
- 8.4. Asia-Pacific
- 8.4.1. Key trends and opportunities
- 8.4.2. Market size and forecast, by Product Type
- 8.4.3. Market size and forecast, by Technique
- 8.4.4. Market size and forecast, by Application
- 8.4.5. Market size and forecast, by End User
- 8.4.6. Market size and forecast, by country
- 8.4.6.1. China
- 8.4.6.1.1. Key market trends, growth factors and opportunities
- 8.4.6.1.2. Market size and forecast, by Product Type
- 8.4.6.1.3. Market size and forecast, by Technique
- 8.4.6.1.4. Market size and forecast, by Application
- 8.4.6.1.5. Market size and forecast, by End User
- 8.4.6.2. Japan
- 8.4.6.2.1. Key market trends, growth factors and opportunities
- 8.4.6.2.2. Market size and forecast, by Product Type
- 8.4.6.2.3. Market size and forecast, by Technique
- 8.4.6.2.4. Market size and forecast, by Application
- 8.4.6.2.5. Market size and forecast, by End User
- 8.4.6.3. India
- 8.4.6.3.1. Key market trends, growth factors and opportunities
- 8.4.6.3.2. Market size and forecast, by Product Type
- 8.4.6.3.3. Market size and forecast, by Technique
- 8.4.6.3.4. Market size and forecast, by Application
- 8.4.6.3.5. Market size and forecast, by End User
- 8.4.6.4. Australia
- 8.4.6.4.1. Key market trends, growth factors and opportunities
- 8.4.6.4.2. Market size and forecast, by Product Type
- 8.4.6.4.3. Market size and forecast, by Technique
- 8.4.6.4.4. Market size and forecast, by Application
- 8.4.6.4.5. Market size and forecast, by End User
- 8.4.6.5. South Korea
- 8.4.6.5.1. Key market trends, growth factors and opportunities
- 8.4.6.5.2. Market size and forecast, by Product Type
- 8.4.6.5.3. Market size and forecast, by Technique
- 8.4.6.5.4. Market size and forecast, by Application
- 8.4.6.5.5. Market size and forecast, by End User
- 8.4.6.6. Rest of Asia-Pacific
- 8.4.6.6.1. Key market trends, growth factors and opportunities
- 8.4.6.6.2. Market size and forecast, by Product Type
- 8.4.6.6.3. Market size and forecast, by Technique
- 8.4.6.6.4. Market size and forecast, by Application
- 8.4.6.6.5. Market size and forecast, by End User
- 8.5. LAMEA
- 8.5.1. Key trends and opportunities
- 8.5.2. Market size and forecast, by Product Type
- 8.5.3. Market size and forecast, by Technique
- 8.5.4. Market size and forecast, by Application
- 8.5.5. Market size and forecast, by End User
- 8.5.6. Market size and forecast, by country
- 8.5.6.1. Brazil
- 8.5.6.1.1. Key market trends, growth factors and opportunities
- 8.5.6.1.2. Market size and forecast, by Product Type
- 8.5.6.1.3. Market size and forecast, by Technique
- 8.5.6.1.4. Market size and forecast, by Application
- 8.5.6.1.5. Market size and forecast, by End User
- 8.5.6.2. Saudi Arabia
- 8.5.6.2.1. Key market trends, growth factors and opportunities
- 8.5.6.2.2. Market size and forecast, by Product Type
- 8.5.6.2.3. Market size and forecast, by Technique
- 8.5.6.2.4. Market size and forecast, by Application
- 8.5.6.2.5. Market size and forecast, by End User
- 8.5.6.3. South Africa
- 8.5.6.3.1. Key market trends, growth factors and opportunities
- 8.5.6.3.2. Market size and forecast, by Product Type
- 8.5.6.3.3. Market size and forecast, by Technique
- 8.5.6.3.4. Market size and forecast, by Application
- 8.5.6.3.5. Market size and forecast, by End User
- 8.5.6.4. Rest of LAMEA
- 8.5.6.4.1. Key market trends, growth factors and opportunities
- 8.5.6.4.2. Market size and forecast, by Product Type
- 8.5.6.4.3. Market size and forecast, by Technique
- 8.5.6.4.4. Market size and forecast, by Application
- 8.5.6.4.5. Market size and forecast, by End User
- CHAPTER 9: COMPETITIVE LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Top player positioning, 2021
- CHAPTER 10: COMPANY PROFILES
- 10.1. Argon Medical Devices, Inc.
- 10.1.1. Company overview
- 10.1.2. Key Executives
- 10.1.3. Company snapshot
- 10.1.4. Operating business segments
- 10.1.5. Product portfolio
- 10.2. Eckert & Ziegler BEBIG
- 10.2.1. Company overview
- 10.2.2. Key Executives
- 10.2.3. Company snapshot
- 10.2.4. Operating business segments
- 10.2.5. Product portfolio
- 10.2.6. Business performance
- 10.3. Elekta AB
- 10.3.1. Company overview
- 10.3.2. Key Executives
- 10.3.3. Company snapshot
- 10.3.4. Operating business segments
- 10.3.5. Product portfolio
- 10.3.6. Business performance
- 10.4. iCAD, Inc.
- 10.4.1. Company overview
- 10.4.2. Key Executives
- 10.4.3. Company snapshot
- 10.4.4. Operating business segments
- 10.4.5. Product portfolio
- 10.4.6. Business performance
- 10.5. isoray medical, inc.
- 10.5.1. Company overview
- 10.5.2. Key Executives
- 10.5.3. Company snapshot
- 10.5.4. Operating business segments
- 10.5.5. Product portfolio
- 10.5.6. Business performance
- 10.5.7. Key strategic moves and developments
- 10.6. Merit Medical Systems, Inc.
- 10.6.1. Company overview
- 10.6.2. Key Executives
- 10.6.3. Company snapshot
- 10.6.4. Operating business segments
- 10.6.5. Product portfolio
- 10.6.6. Business performance
- 10.7. Theragenics Corporation
- 10.7.1. Company overview
- 10.7.2. Key Executives
- 10.7.3. Company snapshot
- 10.7.4. Operating business segments
- 10.7.5. Product portfolio
- 10.8. Siemens AG
- 10.8.1. Company overview
- 10.8.2. Key Executives
- 10.8.3. Company snapshot
- 10.8.4. Operating business segments
- 10.8.5. Product portfolio
- 10.8.6. Business performance
- 10.8.7. Key strategic moves and developments
- 10.9. IsoAid
- 10.9.1. Company overview
- 10.9.2. Key Executives
- 10.9.3. Company snapshot
- 10.9.4. Operating business segments
- 10.9.5. Product portfolio
- 10.10. Carl Zeiss AG
- 10.10.1. Company overview
- 10.10.2. Key Executives
- 10.10.3. Company snapshot
- 10.10.4. Operating business segments
- 10.10.5. Product portfolio
- 10.10.6. Business performance
- LIST OF TABLES
- TABLE 01. GLOBAL BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 02. BRACHYTHERAPY MARKET FOR SEEDS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 03. BRACHYTHERAPY MARKET FOR APPLICATORS AND AFTERLOADERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 04. BRACHYTHERAPY MARKET FOR ELECTRONIC BRACHYTHERAPY, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 05. GLOBAL BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 06. BRACHYTHERAPY MARKET FOR HIGH DOSE RATE (HDR), BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 07. BRACHYTHERAPY MARKET FOR LOW DOSE RATE (LDR), BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 08. GLOBAL BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 09. BRACHYTHERAPY MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 10. BRACHYTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 11. BRACHYTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 12. BRACHYTHERAPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 13. GLOBAL BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 14. BRACHYTHERAPY MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 15. BRACHYTHERAPY MARKET FOR SPECIALTY CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 16. BRACHYTHERAPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 17. BRACHYTHERAPY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 18. NORTH AMERICA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 19. NORTH AMERICA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 20. NORTH AMERICA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 21. NORTH AMERICA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 22. NORTH AMERICA BRACHYTHERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 23. U.S. BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 24. U.S. BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 25. U.S. BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 26. U.S. BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 27. CANADA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 28. CANADA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 29. CANADA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 30. CANADA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 31. MEXICO BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 32. MEXICO BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 33. MEXICO BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 34. MEXICO BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 35. EUROPE BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 36. EUROPE BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 37. EUROPE BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 38. EUROPE BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 39. EUROPE BRACHYTHERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 40. GERMANY BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 41. GERMANY BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 42. GERMANY BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 43. GERMANY BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 44. FRANCE BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 45. FRANCE BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 46. FRANCE BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 47. FRANCE BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 48. UK BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 49. UK BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 50. UK BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 51. UK BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 52. ITALY BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 53. ITALY BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 54. ITALY BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 55. ITALY BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 56. SPAIN BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 57. SPAIN BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 58. SPAIN BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 59. SPAIN BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 60. REST OF EUROPE BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 61. REST OF EUROPE BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 62. REST OF EUROPE BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 63. REST OF EUROPE BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 64. ASIA-PACIFIC BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 65. ASIA-PACIFIC BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 66. ASIA-PACIFIC BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 67. ASIA-PACIFIC BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 68. ASIA-PACIFIC BRACHYTHERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 69. CHINA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 70. CHINA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 71. CHINA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 72. CHINA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 73. JAPAN BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 74. JAPAN BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 75. JAPAN BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 76. JAPAN BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 77. INDIA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 78. INDIA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 79. INDIA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 80. INDIA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 81. AUSTRALIA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 82. AUSTRALIA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 83. AUSTRALIA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 84. AUSTRALIA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 85. SOUTH KOREA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 86. SOUTH KOREA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 87. SOUTH KOREA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 88. SOUTH KOREA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 89. REST OF ASIA-PACIFIC BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 90. REST OF ASIA-PACIFIC BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 91. REST OF ASIA-PACIFIC BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 92. REST OF ASIA-PACIFIC BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 93. LAMEA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 94. LAMEA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 95. LAMEA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 96. LAMEA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 97. LAMEA BRACHYTHERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 98. BRAZIL BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 99. BRAZIL BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 100. BRAZIL BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 101. BRAZIL BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 102. SAUDI ARABIA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 103. SAUDI ARABIA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 104. SAUDI ARABIA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 105. SAUDI ARABIA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 106. SOUTH AFRICA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 107. SOUTH AFRICA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 108. SOUTH AFRICA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 109. SOUTH AFRICA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 110. REST OF LAMEA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 111. REST OF LAMEA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
- TABLE 112. REST OF LAMEA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 113. REST OF LAMEA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 114. ARGON MEDICAL DEVICES, INC.: KEY EXECUTIVES
- TABLE 115. ARGON MEDICAL DEVICES, INC.: COMPANY SNAPSHOT
- TABLE 116. ARGON MEDICAL DEVICES, INC.: PRODUCT SEGMENTS
- TABLE 117. ARGON MEDICAL DEVICES, INC.: PRODUCT PORTFOLIO
- TABLE 118. ECKERT & ZIEGLER BEBIG: KEY EXECUTIVES
- TABLE 119. ECKERT & ZIEGLER BEBIG: COMPANY SNAPSHOT
- TABLE 120. ECKERT & ZIEGLER BEBIG: PRODUCT SEGMENTS
- TABLE 121. ECKERT & ZIEGLER BEBIG: PRODUCT PORTFOLIO
- TABLE 122. ELEKTA AB: KEY EXECUTIVES
- TABLE 123. ELEKTA AB: COMPANY SNAPSHOT
- TABLE 124. ELEKTA AB: PRODUCT SEGMENTS
- TABLE 125. ELEKTA AB: PRODUCT PORTFOLIO
- TABLE 126. ICAD, INC.: KEY EXECUTIVES
- TABLE 127. ICAD, INC.: COMPANY SNAPSHOT
- TABLE 128. ICAD, INC.: PRODUCT SEGMENTS
- TABLE 129. ICAD, INC.: PRODUCT PORTFOLIO
- TABLE 130. ISORAY MEDICAL, INC.: KEY EXECUTIVES
- TABLE 131. ISORAY MEDICAL, INC.: COMPANY SNAPSHOT
- TABLE 132. ISORAY MEDICAL, INC.: PRODUCT SEGMENTS
- TABLE 133. ISORAY MEDICAL, INC.: PRODUCT PORTFOLIO
- TABLE 134. ISORAY MEDICAL, INC.: KEY STRATERGIES
- TABLE 135. MERIT MEDICAL SYSTEMS, INC.: KEY EXECUTIVES
- TABLE 136. MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
- TABLE 137. MERIT MEDICAL SYSTEMS, INC.: PRODUCT SEGMENTS
- TABLE 138. MERIT MEDICAL SYSTEMS, INC.: PRODUCT PORTFOLIO
- TABLE 139. THERAGENICS CORPORATION: KEY EXECUTIVES
- TABLE 140. THERAGENICS CORPORATION: COMPANY SNAPSHOT
- TABLE 141. THERAGENICS CORPORATION: PRODUCT SEGMENTS
- TABLE 142. THERAGENICS CORPORATION: PRODUCT PORTFOLIO
- TABLE 143. SIEMENS AG: KEY EXECUTIVES
- TABLE 144. SIEMENS AG: COMPANY SNAPSHOT
- TABLE 145. SIEMENS AG: PRODUCT SEGMENTS
- TABLE 146. SIEMENS AG: PRODUCT PORTFOLIO
- TABLE 147. SIEMENS AG: KEY STRATERGIES
- TABLE 148. ISOAID: KEY EXECUTIVES
- TABLE 149. ISOAID: COMPANY SNAPSHOT
- TABLE 150. ISOAID: PRODUCT SEGMENTS
- TABLE 151. ISOAID: PRODUCT PORTFOLIO
- TABLE 152. CARL ZEISS AG: KEY EXECUTIVES
- TABLE 153. CARL ZEISS AG: COMPANY SNAPSHOT
- TABLE 154. CARL ZEISS AG: PRODUCT SEGMENTS
- TABLE 155. CARL ZEISS AG: PRODUCT PORTFOLIO
- LIST OF FIGURES
- FIGURE 01. BRACHYTHERAPY MARKET, 2021-2031
- FIGURE 02. SEGMENTATION OF BRACHYTHERAPY MARKET, 2021-2031
- FIGURE 03. TOP INVESTMENT POCKETS IN BRACHYTHERAPY MARKET (2022-2031)
- FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 06. MODERATE THREAT OF SUBSTITUTES
- FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 08. MODERATE INTENSITY OF RIVALRY
- FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALBRACHYTHERAPY MARKET
- FIGURE 10. BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021(%)
- FIGURE 11. COMPARATIVE SHARE ANALYSIS OF BRACHYTHERAPY MARKET FOR SEEDS, BY COUNTRY 2021-2031(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF BRACHYTHERAPY MARKET FOR APPLICATORS AND AFTERLOADERS, BY COUNTRY 2021-2031(%)
- FIGURE 13. COMPARATIVE SHARE ANALYSIS OF BRACHYTHERAPY MARKET FOR ELECTRONIC BRACHYTHERAPY, BY COUNTRY 2021-2031(%)
- FIGURE 14. BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021(%)
- FIGURE 15. COMPARATIVE SHARE ANALYSIS OF BRACHYTHERAPY MARKET FOR HIGH DOSE RATE (HDR), BY COUNTRY 2021-2031(%)
- FIGURE 16. COMPARATIVE SHARE ANALYSIS OF BRACHYTHERAPY MARKET FOR LOW DOSE RATE (LDR), BY COUNTRY 2021-2031(%)
- FIGURE 17. BRACHYTHERAPY MARKET, BY APPLICATION, 2021(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF BRACHYTHERAPY MARKET FOR GYNECOLOGICAL CANCER, BY COUNTRY 2021-2031(%)
- FIGURE 19. COMPARATIVE SHARE ANALYSIS OF BRACHYTHERAPY MARKET FOR PROSTATE CANCER, BY COUNTRY 2021-2031(%)
- FIGURE 20. COMPARATIVE SHARE ANALYSIS OF BRACHYTHERAPY MARKET FOR BREAST CANCER, BY COUNTRY 2021-2031(%)
- FIGURE 21. COMPARATIVE SHARE ANALYSIS OF BRACHYTHERAPY MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
- FIGURE 22. BRACHYTHERAPY MARKET, BY END USER, 2021(%)
- FIGURE 23. COMPARATIVE SHARE ANALYSIS OF BRACHYTHERAPY MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
- FIGURE 24. COMPARATIVE SHARE ANALYSIS OF BRACHYTHERAPY MARKET FOR SPECIALTY CLINICS, BY COUNTRY 2021-2031(%)
- FIGURE 25. COMPARATIVE SHARE ANALYSIS OF BRACHYTHERAPY MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
- FIGURE 26. BRACHYTHERAPY MARKET BY REGION, 2021
- FIGURE 27. U.S. BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 28. CANADA BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 29. MEXICO BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 30. GERMANY BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 31. FRANCE BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 32. UK BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 33. ITALY BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 34. SPAIN BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 35. REST OF EUROPE BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 36. CHINA BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 37. JAPAN BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 38. INDIA BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 39. AUSTRALIA BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 40. SOUTH KOREA BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 41. REST OF ASIA-PACIFIC BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 42. BRAZIL BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 43. SAUDI ARABIA BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 44. SOUTH AFRICA BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 45. REST OF LAMEA BRACHYTHERAPY MARKET, 2021-2031 ($MILLION)
- FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 50. COMPETITIVE DASHBOARD
- FIGURE 51. COMPETITIVE HEATMAP: BRACHYTHERAPY MARKET
- FIGURE 52. TOP PLAYER POSITIONING, 2021
- FIGURE 53. ECKERT & ZIEGLER BEBIG: NET SALES, 2019-2021 ($MILLION)
- FIGURE 54. ECKERT & ZIEGLER BEBIG: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 55. ECKERT & ZIEGLER BEBIG: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 56. ELEKTA AB: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 57. ELEKTA AB: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 58. ELEKTA AB: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 59. ICAD, INC.: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 60. ICAD, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 61. ISORAY MEDICAL, INC.: NET SALES, 2019-2021 ($MILLION)
- FIGURE 62. ISORAY MEDICAL, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 63. MERIT MEDICAL SYSTEMS, INC.: NET SALES, 2019-2021 ($MILLION)
- FIGURE 64. MERIT MEDICAL SYSTEMS, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
- FIGURE 65. MERIT MEDICAL SYSTEMS, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 66. MERIT MEDICAL SYSTEMS, INC.: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 67. SIEMENS AG: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 68. S
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook